NOTCH2-FL, FLT3-FL, and their splice variant expression profiles reflect disease status
| Samples . | NOTCH2 variants . | FLT3 variants . | ||||
|---|---|---|---|---|---|---|
| -FL [n (%)] . | -Va [n (%)] . | -FL [n (%)] . | -Va [n (%)] . | -Vb [n (%)] . | -Vc [n (%)] . | |
| Diagnosis (n = 14) | 14 (100%) | 11 (79%) | 14 (100%) | 9 (64%) | 5 (36%) | 11 (79%) |
| Remission (n = 5) | 5 (100%) | 3 (60%) | 5 (100%) | 0 (0%) | 2 (40) | 1 (20%) |
| Relapse (n = 10) | 8 (80%) | 8 (80%) | 8 (80%) | 8 (80%) | 6 (60%) | 7 (70%) |
| Persistent AML (n = 6) | 6 (100%) | 6 (100%) | 6 (100%) | 5 (83%) | 6 (100%) | 5 (83%) |
| Samples . | NOTCH2 variants . | FLT3 variants . | ||||
|---|---|---|---|---|---|---|
| -FL [n (%)] . | -Va [n (%)] . | -FL [n (%)] . | -Va [n (%)] . | -Vb [n (%)] . | -Vc [n (%)] . | |
| Diagnosis (n = 14) | 14 (100%) | 11 (79%) | 14 (100%) | 9 (64%) | 5 (36%) | 11 (79%) |
| Remission (n = 5) | 5 (100%) | 3 (60%) | 5 (100%) | 0 (0%) | 2 (40) | 1 (20%) |
| Relapse (n = 10) | 8 (80%) | 8 (80%) | 8 (80%) | 8 (80%) | 6 (60%) | 7 (70%) |
| Persistent AML (n = 6) | 6 (100%) | 6 (100%) | 6 (100%) | 5 (83%) | 6 (100%) | 5 (83%) |